BC Week In Review | Jun 27, 2011
Company News

RepRegen board of directors update

RepRegen Ltd. , London, U.K.   Business: Musculoskeletal   Resigned: Stephan Rietiker as chairman; non-executive Director Ron Peterson becomes interim chairman  ...
BC Week In Review | Nov 22, 2010
Financial News

RepRegen completes venture financing

RepRegen Ltd. , London, U.K.   Business: Musculoskeletal   Date completed: 11/16/10   Type: Venture financing   Raised: £1 million ($1.7 million)   Investors: Imperial Innovations Group plc ; Longbow Capital; existing investors  ...
BC Innovations | Aug 19, 2010
Tools & Techniques

Cell-free joint regeneration

Columbia University Medical Center researchers have identified a cell-free tissue-regeneration strategy that not only helps replace lost bone but also regenerates cartilage, a feat that has stymied previous joint replacement efforts. 1 Treatments for the...
BC Week In Review | Jul 12, 2010
Clinical News

StronBone regulatory update

RepRegen received CE mark approval in the EU for its StronBone bone graft substitute for hard tissue repair and regeneration. The company, which spun out of Imperial Innovations Group plc (LSE:IVO, London, U.K.), hopes to...
BC Week In Review | Mar 15, 2010
Clinical News

RepRegen preclinical data

In human osteoblasts, RepRegen's strontium-based bioactive glass promoted osteoblast cell activity and proliferation. Data were presented at the Orthopedic Research Society meeting in New Orleans. RepRegen Ltd. , London, U.K.   Product: Strontium-based bioactive glass  ...
BC Week In Review | Jan 18, 2010
Company News

BioCeramic Therapeutics management update

BioCeramic Therapeutics Ltd. , London, U.K.   Business: Musculoskeletal   Hired: Ian Brown as CEO, formerly managing director and CEO of SDP Technology Ltd. and managing director of Avanti Capital; he replaces Daniel Green, who will...
BC Week In Review | Oct 26, 2009
Financial News

BioCeramic Therapeutics completes venture financing

BioCeramic Therapeutics Ltd. , London, U.K.   Business: Musculoskeletal   Date completed: 10/20/09   Type: Venture financing   Raised: £1.1 million ($1.8 million)   Investors: Imperial Innovations Group; Longbow Capital; ComVest; Esmee Fairbairn Foundation  ...
BC Week In Review | Oct 26, 2009
Company News

BioCeramic Therapeutics board of directors update

BioCeramic Therapeutics Ltd. , London, U.K.   Business: Musculoskeletal   Appointed: Stephan Rietiker, a director, as chairman  ...
Items per page:
1 - 8 of 8
BC Week In Review | Jun 27, 2011
Company News

RepRegen board of directors update

RepRegen Ltd. , London, U.K.   Business: Musculoskeletal   Resigned: Stephan Rietiker as chairman; non-executive Director Ron Peterson becomes interim chairman  ...
BC Week In Review | Nov 22, 2010
Financial News

RepRegen completes venture financing

RepRegen Ltd. , London, U.K.   Business: Musculoskeletal   Date completed: 11/16/10   Type: Venture financing   Raised: £1 million ($1.7 million)   Investors: Imperial Innovations Group plc ; Longbow Capital; existing investors  ...
BC Innovations | Aug 19, 2010
Tools & Techniques

Cell-free joint regeneration

Columbia University Medical Center researchers have identified a cell-free tissue-regeneration strategy that not only helps replace lost bone but also regenerates cartilage, a feat that has stymied previous joint replacement efforts. 1 Treatments for the...
BC Week In Review | Jul 12, 2010
Clinical News

StronBone regulatory update

RepRegen received CE mark approval in the EU for its StronBone bone graft substitute for hard tissue repair and regeneration. The company, which spun out of Imperial Innovations Group plc (LSE:IVO, London, U.K.), hopes to...
BC Week In Review | Mar 15, 2010
Clinical News

RepRegen preclinical data

In human osteoblasts, RepRegen's strontium-based bioactive glass promoted osteoblast cell activity and proliferation. Data were presented at the Orthopedic Research Society meeting in New Orleans. RepRegen Ltd. , London, U.K.   Product: Strontium-based bioactive glass  ...
BC Week In Review | Jan 18, 2010
Company News

BioCeramic Therapeutics management update

BioCeramic Therapeutics Ltd. , London, U.K.   Business: Musculoskeletal   Hired: Ian Brown as CEO, formerly managing director and CEO of SDP Technology Ltd. and managing director of Avanti Capital; he replaces Daniel Green, who will...
BC Week In Review | Oct 26, 2009
Financial News

BioCeramic Therapeutics completes venture financing

BioCeramic Therapeutics Ltd. , London, U.K.   Business: Musculoskeletal   Date completed: 10/20/09   Type: Venture financing   Raised: £1.1 million ($1.8 million)   Investors: Imperial Innovations Group; Longbow Capital; ComVest; Esmee Fairbairn Foundation  ...
BC Week In Review | Oct 26, 2009
Company News

BioCeramic Therapeutics board of directors update

BioCeramic Therapeutics Ltd. , London, U.K.   Business: Musculoskeletal   Appointed: Stephan Rietiker, a director, as chairman  ...
Items per page:
1 - 8 of 8